Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAmati Aim Vct Regulatory News (AMAT)

Share Price Information for Amati Aim Vct (AMAT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 85.50
Bid: 85.00
Ask: 86.00
Change: 0.00 (0.00%)
Spread: 1.00 (1.176%)
Open: 85.50
High: 85.50
Low: 85.50
Prev. Close: 85.50
AMAT Live PriceLast checked at -
Amati AIM VCT is an Investment Trust

To generate tax free capital gains and regular dividend income, invests primarily in AIM-traded companies and non-qualifying investments as allowed by the VCT legislation.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Offer for subscription

1 Feb 2019 07:00

RNS Number : 7190O
Amati AIM VCT PLC
01 February 2019
 

1 February 2019

 

 

Amati AIM VCT plc (the "Company")

Legal Entity Identifier: 213800HAEDBBK9RWCD25

 

Offer for Subscription

The Directors of Amati AIM VCT plc are pleased to announce that the Company has today published a top up offer document (the "Information Document") in connection with proposals to raise up to approximately £7 million, by way of offers for subscription of new ordinary shares (the "Offer").

The Offer, which is being managed under the limits applicable to non-prospectus rules, opens on Friday 1 February 2019 and is expected to close at noon on Thursday 4 April 2019 in respect of the 2018/2019 tax year and at noon on Friday 12 July 2019 in respect of the 2019/2020 tax year (or on an earlier date if the maximum subscription is received). While applications are invited from both existing shareholders and new investors, existing shareholders will be given priority to subscribe until 18 February 2019. Once demand from existing shareholders who have applied during this initial period is satisfied, all further applications will be processed on a first come, first served basis, subject to the discretion of the directors. The directors may, at their discretion, close the Offer earlier than indicated or decide to extend the Offer.

The Offer is being managed such that existing shareholders submitting applications received on or before 18 February 2019 will receive their full requested allocation insofar as the capacity of the Offer allows. Should the offer be fully or over-subscribed during this initial period, existing shareholders will be guaranteed their pre-emption entitlement, which will be determined in proportion to the number of shares held.

Further, existing shareholders applying during the initial period will not be subject to the minimum subscription requirement per investor of £4,000 per tax year, so it is therefore not necessary to make a distinction between shares applied for under pre-emption rights and those applied for under the general Offer. Should existing shareholders decide to apply within the initial period of the Offer in order to secure their pre-emption entitlement, they should apply in the normal way, for the total monetary amount for which they wish to subscribe, and the Company will contact applicants in the event that a scaling back of allocations becomes necessary (subject to the minimum entitlement).

The new ordinary shares will be issued at a price determined in accordance with a formula to allow for issue costs (as set out in the Offer Document) and based on the last published net asset value per share ("NAV per Share") of the Company prior to the date of issue. The NAV per Share will be divided by 0.99 to determine the issue price for applications from existing shareholders and shares issued in respect of applications received through authorised financial intermediaries, which allows for issue costs of 1%. For all other applications the NAV per Share will be divided by 0.97 to determine the issue price, which allows for issue costs of 3%. Upon issue, the new ordinary shares will be admitted to the Official List of the UKLA and to trading on the Main Market of the London Stock Exchange.

The Information Document and the covering circular to shareholders (the "Letter") with details of the pre-emption offer are available to download at www.amatiglobal.com or you can contact Amati Global Investors by phone on 0131 503 9115 or by email at info@amatiglobal.com to request hard copies. These documents will also be submitted to the National Storage Mechanism for viewing online at www.morningstar.co.uk/uk/NSM.

For further information please contact Samantha Dalby on 0131 503 9115 or email info@amatiglobal.com.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
STRBBMJTMBAJBIL
Date   Source Headline
1st Dec 20224:39 pmRNSBoard Committee Change
1st Dec 20224:19 pmRNSTotal Voting Rights
28th Nov 202210:35 amRNSDirector/PDMR Shareholding
25th Nov 20224:56 pmRNSIssue of Equity - DRIS
25th Nov 20223:29 pmRNSNet Asset Value(s)
21st Nov 20222:52 pmRNSTransaction in Own Shares
18th Nov 20224:15 pmRNSNet Asset Value(s)
11th Nov 20223:42 pmRNSNet Asset Value(s)
4th Nov 20222:40 pmRNSNet Asset Value(s)
1st Nov 20225:32 pmRNSNet Asset Value(s)
1st Nov 202210:06 amRNSTotal Voting Rights
24th Oct 202210:45 amRNSNet Asset Value(s)
21st Oct 20223:09 pmRNSTransaction in Own Shares
17th Oct 202212:04 pmRNSNet Asset Value(s)
12th Oct 20225:19 pmRNSTransaction in Own Shares
10th Oct 20222:40 pmRNSNet Asset Value(s)
4th Oct 20221:50 pmRNSNet Asset Value(s)
3rd Oct 20229:16 amRNSTotal Voting Rights
30th Sep 20227:01 amRNSDividend Declaration
30th Sep 20227:00 amRNSHalf-year Report
28th Sep 20223:02 pmRNSTransaction in Own Shares
23rd Sep 20224:09 pmRNSNet Asset Value(s)
23rd Sep 20223:56 pmRNSTransaction in Own Shares
22nd Sep 202210:53 amRNSTransaction in Own Shares
16th Sep 20225:19 pmRNSNet Asset Value(s)
13th Sep 20223:10 pmRNSCancellation of Share Premium Account
9th Sep 20223:02 pmRNSNet Asset Value(s)
7th Sep 20221:56 pmRNSTransaction in Own Shares
2nd Sep 202210:40 amRNSReplacement Total Voting Rights
1st Sep 20225:08 pmRNSTotal Voting Rights
1st Sep 20224:26 pmRNSTransaction in Own Shares
1st Sep 20223:48 pmRNSNet Asset Value(s)
30th Aug 20224:14 pmRNSCompliance with Market Abuse Regulation
30th Aug 20229:05 amRNSNet Asset Value(s)
22nd Aug 20222:20 pmRNSTransaction in Own Shares
19th Aug 20224:43 pmRNSNet Asset Value(s)
16th Aug 20224:18 pmRNSTransaction in Own Shares
12th Aug 20223:47 pmRNSNet Asset Value(s)
5th Aug 20223:03 pmRNSNet Asset Value(s)
2nd Aug 202210:54 amRNSNet Asset Value(s)
1st Aug 202210:56 amRNSTotal Voting Rights
25th Jul 20222:05 pmRNSDirector/PDMR Shareholding
22nd Jul 20224:25 pmRNSIssue of Equity - DRIS
22nd Jul 20222:46 pmRNSNet Asset Value(s)
15th Jul 20223:53 pmRNSNet Asset Value(s)
13th Jul 202212:53 pmRNSTransaction in Own Shares
8th Jul 20225:24 pmRNSNet Asset Value(s)
4th Jul 20229:57 amRNSNet Asset Value(s)
1st Jul 20221:33 pmRNSTotal Voting Rights
30th Jun 20223:43 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.